Senti Biosciences
IPOHome - Senti Bio
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- sentibio.com
- Total Funding
- $205.6M
- Last Round
- $47.6M Corporate RoundDec 2024
- Rounds
- 4
- Type
- Public
About
Senti Biosciences is a clinical-stage biotechnology company developing next-generation cell and gene therapies using proprietary Gene Circuit technology. Founded in 2016 and headquartered in South San Francisco, California, Senti Bio programs synthetic biology logic gates into cells to create smarter medicines for oncology and other incurable diseases.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Dec 2024
Dec 2024
Jan 2021
Feb 2018
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...